GE HealthCare to highlight AI-enabled solutions at ESTRO 2026 Congress

At the European Society for Radiotherapy and Oncology 2026 Congress in Stockholm, GE HealthCare (GEHC) will highlight a portfolio of AI-enabled solutions designed to support clinicians across radiation therapy, theranostics, and image-guided interventions. At ESTRO 2026, GE HealthCare will host live demonstrations of Intelligent Radiation Therapy, an AI-supported software solution for radiation therapy workflow management designed to reduce the time it takes for patients to progress from diagnosis to treatment. Through integration with treatment planning solutions, iRT automates the simulation to treatment plan workflow, helping clinicians create plans in just minutes. Early adopters of iRT have reduced simulation to treatment planning time from seven days to seven minutes through integration with RayStation by RaySearch Laboratories.ii This is made possible by connecting CT imaging directly to plan generation as data moves automatically to RayStation for segmentation and optimization. Alongside CT-based workflows, GE HealthCare will showcase a dedicated MR-only workflow, iRT MR Directiv, which connects to MR Contour DL, a GE HealthCare developed AI model that automatically contours organs at risk on MR images, including head & neck and pelvis. The solution also features MRI Planner, by Spectronic Medical, a deep learning application designed to generate synthetic CT images using standard MR imaging sequences of the brain, head & neck, and pelvis for MRI-only radiotherapy planning purposes. As a first introduction to European audiences, GE HealthCare will also showcase the newly developed iRT for Theranostics. Theranostics treatments often require coordination across multiple specialties, systems, and data sources, making it difficult for clinicians to maintain a clear, end-to-end view of the patient journey. Additionally, GE HealthCare will highlight advanced oncology solutions from MIM software, designed to help clinicians manage growing data volumes while maintaining efficiency and confidence in decision making. GE HealthCare will also showcase key surgical visualization and guidance solutions that reflect how this technology is rooted within the company’s broader oncology portfolio.